2021
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE et. al.Základní údaje
Originální název
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
Autoři
CARDOSO, R., F. GUO, T. HEISSER, M. HACKL, P. IHLE, H. DE SCHUTTER, N. VAN DAMME, Z. VALERIANOVA, T. ATANASOV, Ondřej MÁJEK (203 Česká republika, domácí), Jan MUŽÍK (203 Česká republika, domácí), M. C. NILBERT, A. J. TYBJERG, K. INNOS, M. MAGI, N. MALILA, A. M. BOUVIER, V. BOUVIER, G. LAUNOY, A. S. WORONOFF, M. CARIOU, M. ROBASZKIEWICZ, P. DELAFOSSE, F. PONCET, A. KATALINIC, P. M. WALSH, C. SENORE, S. ROSSO, I. VINCERZEVSKIENE, V. E. P. P. LEMMENS, M. A. G. ELFERINK, T. B. JOHANNESEN, H. KORNER, F. PFEFFER, M. J. BENTO, J. RODRIGUES, F. A. DA COSTA, A. MIRANDA, V. ZADNIK, T. ZAGAR, A. L. D. MARQUES, R. MARCOS-GRAGERA, M. PUIGDEMONT, J. GALCERAN, M. CARULLA, M. D. CHIRLAQUE, M. BALLESTA, K. SUNDQUIST, J. SUNDQUIST, M. WEBER, A. JORDAN, C. HERRMANN, M. MOUSAVI, A. RYZHOV, M. HOFFMEISTER a H. BRENNER (garant)
Vydání
Lancet Oncology, New York, Elsevier Science INC, 2021, 1470-2045
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30204 Oncology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 54.433
Kód RIV
RIV/00216224:14110/21:00121970
Organizační jednotka
Lékařská fakulta
UT WoS
000668269600045
Klíčová slova anglicky
colorectal cancer; incidence; mortality; stage distribution; Europe
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 23. 7. 2021 13:32, Mgr. Tereza Miškechová
Anotace
V originále
Findings In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2 center dot 5% (95% CI -2 center dot 8 to -2 center dot 2) to -1 center dot 6% (-2 center dot 0 to -1 center dot 2) in men and from -2 center dot 4% (-2 center dot 7 to -2 center dot 1) to -1 center dot 3% (-1 center dot 7 to -0 center dot 9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0 center dot 2% (95% CI -1 center dot 4 to 1 center dot 0) to 1 center dot 5% (1 center dot 1 to 1 center dot 8) in men and from -0 center dot 5% (-1 center dot 7 to 0 center dot 6) to 1 center dot 2% (0 center dot 8 to 1 center dot 5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0 center dot 3% (95% CI 0 center dot 1 to 0 center dot 5) to 1 center dot 9% (1 center dot 2 to 2 center dot 6) in men and from 0 center dot 6% (0 center dot 4 to 0 center dot 8) to 1 center dot 1% (0 center dot 8 to 1 center dot 4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes.